SCHEMBL21414385

SCHEMBL21414385

CCC(C)c1ccc(CN2CCN(C)CC2)cn1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.46
▸ MC4R P32245 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ CHKA P35790 4/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ TP53 P04637 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ CA2 P00918 1/20 0.42
▸ NCF1 P14598 1/20 0.42
▸ PRMT6 Q96LA8 1/20 0.42
▸ HRH3 Q9Y5N1 3/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21414378 0.90 ALDH1A1 (0.49) KDM4ENPC1TP53RAB9AALDH1A1
SCHEMBL23108706 0.89 LMNA (0.46) LMNAMC4RKDM4ECHKANPC1
SCHEMBL21414349 0.88 ALDH1A1 (0.50) LMNAKDM4ENPC1TP53RAB9A
SCHEMBL17660303 0.87 LMNA (0.50) LMNAMC4RKDM4ECHKANPC1
SCHEMBL21414369 0.84 CXCR4 (0.44) HRH3MEN1KMT2A
SCHEMBL23707045 0.84 LMNA (0.47) LMNAMC4RKDM4ECHKANPC1
SCHEMBL21414387 0.82 CHKA (0.57) LMNAKDM4ECHKACA2NCF1
SCHEMBL21414381 0.80 HRH3 (0.47) RAB9AHRH3ALDH1A1MEN1KMT2A
SCHEMBL21414345 0.79 KMT2A (0.41) TP53RAB9AHRH3ALDH1A1MEN1
SCHEMBL21414453 0.79 CHEK1 (0.41) TP53RAB9AHRH3ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3546458-B1 ((PYRIDIN-2-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE AND ((PYRIDAZIN-3-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES AS CDK4/6 INHIBITORS FOR TREATING E.G. RHEUMATOID ARTHRITIS, ARTERIOSCLEROSIS, PULMONARY FIBROSIS, CEREBRAL INFARCTION OR CANCER TEIJIN PHARMA LTD (JP) 2021-01-06 — — EP disclosed
EP-3546458-A1 PYRIDO[3, 4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2019-10-02 — — EP disclosed
Send feedback